“We live in a data-driven world, where measuring the impact of our efforts is considered key – but somehow, even with all the recent efforts to prioritize outcomes in our healthcare system, the impact of so much health education remains unevaluated.”

– Robert Rosenbloom, PlatformQ Health’s CEO

Robert Rosenbloom

Our outcomes-driven education measures impact and improvements in a number of facets, including knowledge, communication, behavior, shared decision making, activation, and more. In addition, we’re able offer extended capabilities, like:

  • Metrics that help show learner engagement throughout the activity time in session, slide downloads, poll responses & live questions asked
  • Strategic educational design theories formative evaluation into multi-session activities
  • Deeper qualitative analysis showing greater impact leveraging in-depth interviews and patient activation

Recognized within the industry as leaders in the space, our in-house outcomes and medical team regularly present findings and best practices at medical and industry conferences, have been awarded for excellence by their peers, and serve on industry leadership councils tasked with determining industry-wide outcome standards for CME/CE.

Last Year…

Patients Impacted

Average Time in Session (minutes)

Questions Asked

Poll Questions Answered

Slide Downloads

Disseminating Program Outcomes

We believe efficacy matter more than intent, so we make a point of communicating the results of our programs with all key stakeholders, including learners, supporters, and advocacy partners.  We’re proud to be moving the needle, and that outcomes from our clinician and patient activities have been shared widely.

We’re recognized within the industry as leaders in our space, in part because our in-house outcomes and medical team regularly present findings and best practices at medical and industry conferences, have been awarded for excellence by their peers, and serve on industry leadership councils tasked with determining industry-wide outcome standards for CME/CE.

Conference Presentations & Awards

Abstracts & posters at major medical, industry, and advocacy conferences

Peer Reviewed Journals

Program & impact insights published in peer-reviewed journals

White Papers

White papers published highlighting educational design, outcomes, & educational needs

Video Overviews

Easy-to-share videos highlighting learning objectives and program highlights

Infographics & Reports

At-a-glance infographic reports and full, in-depth reporting allow you to share as much information as you wish internally.

Read more about the impact of our programs

Medlive Announces Acceptance of Two Abstracts at the 66th ASH® Annual Meeting and Exposition

Medlive Announces Acceptance of Two Abstracts at the 66th ASH® Annual Meeting and Exposition

/ Blog, Outcomes, Poster
Medlive, a company focused on empowering clinicians, patients, and caregivers through digital education, is proud to announce that two abstracts have been accepted for presentation at the 66th ASH® Annual Meeting and Exposition taking place December 7 – 10, 2024 in San Diego ... Read More
Evolving Standards of Care in Rett Syndrome Highlight The Need For Continuous Education

Evolving Standards of Care in Rett Syndrome Highlight The Need For Continuous Education

/ Blog, Outcomes, Poster, Rare Disease
The treatment of Rett Syndrome (RTT), a rare, genetic neurological disorder affecting young children that leads to severe impairments, is continuing to evolve. The first therapy was approved in March 2023, and with several investigational assets on the horizon, there is a critical need to educate both community-based clinicians and Centers of Excellence on this change to the standard of care.   ... Read More
Adoption Of Biologics For Uncontrolled Asthma Increases By Non/Low Adopters After Continued Medical Education from Medlive

Adoption Of Biologics For Uncontrolled Asthma Increases By Non/Low Adopters After Continued Medical Education from Medlive

/ Blog, Outcomes, Poster
Asthma, a serious chronic lung disease, affects 26.8 million adults and 4.5 million children in the U.S. according to the American Lung Association.1 Research on the pathophysiology of type 2 inflammation has brought new targeted therapies to market that may make a significant difference for patients affected by uncontrolled moderate-to-severe asthma.2 While these innovative biologics play a significant role in treating disease, integration by healthcare practitioners (HCPs) remains inconsistent due to barriers in provider knowledge and confidence.   ... Read More

Measure Your Education

Learn more about how to take your activities to the next level.

Work With Us